Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

IFNG gene signature

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

IFNG overexpression (6)

IFNG expression (4)

IFNG overexpression (6)

IFNG expression (4)

›

IFNG gene signature	Melanoma	IFNG gene signature	Melanoma	nivolumab Sensitive: B - Late Trials nivolumab Sensitive : B	nivolumab Sensitive: B - Late Trials nivolumab Sensitive : B
IFNG gene signature	Urothelial Cancer	IFNG gene signature	Urothelial Cancer	durvalumab Sensitive: C3 – Early Trials durvalumab Sensitive : C3	durvalumab Sensitive: C3 – Early Trials durvalumab Sensitive : C3
IFNG gene signature	Bladder Cancer	IFNG gene signature	Bladder Cancer	durvalumab Sensitive: C3 – Early Trials durvalumab Sensitive : C3	durvalumab Sensitive: C3 – Early Trials durvalumab Sensitive : C3
IFNG gene signature	Non Small Cell Lung Cancer	IFNG gene signature	Non Small Cell Lung Cancer	durvalumab Sensitive: C3 – Early Trials durvalumab Sensitive : C3	durvalumab Sensitive: C3 – Early Trials durvalumab Sensitive : C3
IFNG gene signature	Squamous Cell Carcinoma of Head and Neck	IFNG gene signature	Squamous Cell Carcinoma of Head and Neck	pembrolizumab Sensitive: C3 – Early Trials pembrolizumab Sensitive : C3	pembrolizumab Sensitive: C3 – Early Trials pembrolizumab Sensitive : C3